(Q36304025)

13 August 2017

1 reference

title

Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers? (English)

1 reference

13 August 2017

0 references

4

Kelly M McMasters

1 reference

13 August 2017

1

Charles R Scoggins

1 reference

13 August 2017

3

Robert C G Martin

1 reference

13 August 2017

Anees B Chagpar

2

1 reference

13 August 2017

publication date

1 September 2005

1 reference

Nature Clinical Practice Oncology

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

9

1 reference

13 August 2017

page(s)

448-455

1 reference

Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Lessons learned from the Sunbelt Melanoma Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Review of sentinel lymph node biopsy and systemic interferon for melanoma: promising but investigational modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

The argument against sentinel node biopsy for malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Sentinel Lymph Node Mapping for Thick (?4-mm) Melanoma: Should We Be Doing It?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Factors predicting failure to identify a sentinel lymph node in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Subareolar versus peritumoral injection for location of the sentinel lymph node

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Revision of the American Joint Committee on Cancer staging system for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Correlation between prognostic factors and increasing age in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

Lymphatic drainage of skin to a sentinel lymph node in a feline model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Technical details of intraoperative lymphatic mapping for early stage melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

The orderly progression of melanoma nodal metastases

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Outcome of patients with melanoma and histologically negative sentinel lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

S100 protein: a marker for human malignant melanomas?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Identifying risk factors for complications following sentinel lymph node biopsy for melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Frequency of nonsentinel lymph node metastasis in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

What good is sentinel lymph node biopsy for melanoma if it does not improve survival?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Lymphatic mapping and sentinel lymphadenectomy for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Lymphatic mapping and sentinel node biopsy in the patient with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma-in-situ.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Biology of lymphatic metastases in breast cancer: lessons learned from sentinel node biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0293

7 January 2021

Identifiers

DOI

10.1038/NCPONC0293

1 reference

13 August 2017

1 reference